SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dishman Pharmaceuticals & Chemicals
Dishman Pharmaceuticals & Chemicals
BSE: 532526|NSE: DISHMAN|ISIN: INE353G01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 22, 16:20
155.85
4.35 (2.87%)
VOLUME 245,273
LIVE
NSE
Aug 22, 16:20
156.05
4.35 (2.87%)
VOLUME 1,103,616
News on Dishman Pharmaceuticals & Chemicals
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dishman Pharma expects earnings to improve in Q3, Q4 

3.17 pm | 21 Aug 2014 |  Source: CNBC-TV18

In an interview to CNBC-TV18’s Anuj Singhal and Sonia Shenoy, Arpit Vyas, Managing Director of Dishman Pharma spoke about the latest happenings in t...

Stocks in news: Claris Life, SpiceJet, Zee Ent, Aurobindo

8.29 am | 21 Aug 2014 |  Source: CNBC-TV18

DLF | Jindal Saw | Claris Life | Bosch | IL&FS Transportation | Spicejet | Jet Airways | Winsome Diamonds | Cairn India | Tata Chemicals | Zee Enterta...

Buy Dishman Pharma; target of Rs 177: Angel Broking

1.28 pm | 19 Aug 2014 |  Source: Moneycontrol.com

Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 177 in its August 18, 2014 research report....

Hold Dishman Pharma; target of Rs 146: Sharekhan

7.37 pm | 18 Aug 2014 |  Source: Moneycontrol.com

Sharekhan has recommended hold rating on Dishman Pharma with a target price of Rs 146, in its research report dated August 14, 2014....

Dishman Pharma consolidated Jun '14 sales at Rs 362.71 crore

3.10 pm | 14 Aug 2014 |  Source: Moneycontrol.com

Dishman Pharmaceuticals & Chemicals has reported a consolidated total income from operations of Rs 362.71 crore and a net profit of Rs 23.81 crore for...

Dishman Pharmaceuticals: Outcome of board meeting

4.08 pm | 13 Aug 2014 |  Source: Moneycontrol.com

Dishman Pharmaceuticals and Chemicals approved the proposal by way of passing an enabling resolution for issue of shares to Qualified Institutional In...

Stocks in news: BHEL, Sun Pharma, ONGC, NMDC, Essar Oil

8.41 am | 13 Aug 2014 |  Source: CNBC-TV18

Tata Steel | ONGC | BHEL | Sun Pharma | BEML | Essar Oil | REC | NMDC | Coal India | Bhushan Steel | STC | Parsvnath | SCI | Opto Circuits | Hathway C...

Bull's Eye: Buy Future Retail, Suven Life, Finolex Cables 

8.53 am | 06 Aug 2014 |  Source: CNBC-TV18

Krish Subramanium, Asit C Mehta Investment Intermediattes advises buying Suven Life Sciences for a target price of Rs 126 and Finolex Cables for a tar...

Buy Dishman Pharma, Exide, Shasun Pharma: Krish Subramanium 

1.14 pm | 05 Aug 2014 |  Source: CNBC-TV18

Krish Subramanium of Asit C Mehta Investment Intermediattes is of the view that one may buy Exide Industries and Axis IT&T....

Bull's Eye: Buy Apollo Tyres, Dishman Pharma, Amtek Auto 

9.01 am | 05 Aug 2014 |  Source: CNBC-TV18

Shahina Mukadam, Varun Capital advises buying TVS Motor Company for a target price of Rs 166 and Apollo Tyres for a target price of Rs 185....

Hold Lupin, buy Dishman Pharma: Ambareesh Baliga 

4.59 pm | 04 Aug 2014 |  Source: CNBC-TV18

Independent Market Expert, Ambareesh Baliga is of the view that one may buy Dishman Pharmaceuticals & Chemicals. He advises holding Lupin....

Stocks in news: Tata Motors, IOC, DLF, Tech Mah, Rel Power

8.21 am | 01 Aug 2014 |  Source: CNBC-TV18

Tata Motors | IOC | DLF | Tech Mahindra | Religare Enterprises | Dalmia Bharat | Redington India | Castrol India | SpiceJet | United Breweries | Relia...

Dishman Pharmaceuticals may test Rs 175-180: Baliga 

11.24 am | 24 Jul 2014 |  Source: CNBC-TV18

Independent Market Expert, Ambareesh Baliga feels that Dishman Pharmaceuticals may test Rs 175-180....

Market overvalued! Time to book profits: Ambareesh Baliga 

9.00 am | 24 Jul 2014 |  Source: CNBC-TV18

According to Baliga, the market valuations are quite expensive right now and it is best to book some profits....

Buy Dishman Pharma; target of Rs 123: Angel Broking

11.59 am | 04 Jun 2014 |  Source: Moneycontrol.com

Brokerage house Angel Broking is bullish on Dishman Pharmaceuticals & Chemicals and has recommended 'Buy' rating on the stock with a target price of R...

Dishman Pharma consolidated Mar '14 sales at Rs 409.42 crore

4.43 pm | 02 Jun 2014 |  Source: Moneycontrol.com

Dishman Pharmaceuticals & Chemicals has reported a sales turnover of Rs 409.42 crore and a net profit of Rs 22.59 crore for the quarter ended Mar '14...

1 2
Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.